Reference
Canino F, et al. Cemiplimab- and nivolumab-induced myasthenia gravis: two clinical cases. Tumori 107: NP123-NP126, No. 6, Dec 2021. Available from: URL: http://doi.org/10.1177/03008916211040559
Rights and permissions
About this article
Cite this article
Cemiplimab/nivolumab. Reactions Weekly 1888, 120 (2022). https://doi.org/10.1007/s40278-022-08462-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-08462-5